Adelaide Research & Scholarship: Search

Search

Results 11-20 of 39 (Search time: 0.002 seconds).

previous
1
2
3
4
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2018	Identification of microRNA biomarkers of response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma using next generation sequencing	Chiam, K.; Mayne, G.; Watson, D.; Woodman, R.; Bright, T.; Michael, M.; Karapetis, C.; Irvine, T.; Phillips, W.; Hummel, R.; Wang, T.; Pimlott, L.; Marri, S.; Astill, D.; Ruszkiewicz, A.; Thompson, S.; Hussey, D.
	2020	Enhanced diagnosis of severe aortic stenosis using artificial intelligence: a proof-of-concept study of 530,871 echocardiograms	Playford, D.; Bordin, E.; Mohamad, R.; Stewart, S.; Strange, G.
	2014	Merkel cell carcinoma of the eyelid management and prognosis	Herbert, H.; Sun, M.; Selva, D.; Fernando, B.; Saleh, G.; Beaconsfield, M.; Collin, R.; Uddin, J.; Meligonis, G.; Leatherbarrow, B.; Ataullah, S.; Irion, L.; McLean, C.; Huilgol, S.; Davis, G.; Sullivan, T.
	2021	Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia	Ochi, Y.; Yoshida, K.; Huang, Y.-J.; Kuo, M.-C.; Nannya, Y.; Sasaki, K.; Mitani, K.; Hosoya, N.; Hiramoto, N.; Ishikawa, T.; Branford, S.; Shanmuganathan, N.; Ohyashiki, K.; Takahashi, N.; Takaku, T.; Tsuchiya, S.; Kanemura, N.; Nakamura, N.; Ueda, Y.; Yoshihara, S.; et al.
	2019	Alpha-Blockers as colorectal cancer chemopreventive: findings from a case-control study, human cell cultures, and in vivo preclinical testing	Suzuki, N.; Niikura, R.; Ihara, S.; Hikiba, Y.; Kinoshita, H.; Higashishima, N.; Hayakawa, Y.; Yamada, A.; Hirata, Y.; Nakata, R.; Okamoto, M.; Sano, M.; Kushiyama, A.; Ichinose, M.; Woods, S.L.; Worthley, D.; Iwamoto, Y.; Koike, K.
	2015	Myocardial injury after transaortic versus transapical transcatheter aortic valve replacement	Ribeiro, H.; Dahou, A.; Urena, M.; Carrasco, J.; Mohammadi, S.; Doyle, D.; Le Ven, F.; Allende, R.; Amat-Santos, I.; Paradis, J.; DeLarochellière, R.; Puri, R.; Abdul-Jawad Altisent, O.; del Trigo, M.; Campelo-Parada, F.; Pibarot, P.; Dumont, É.; Rodés-Cabau, J.
	2015	Phase 2 study of intralesional PV-10 in refractory metastatic melanoma	Thompson, J.; Agarwala, S.; Smithers, B.; Ross, M.; Scoggins, C.; Coventry, B.; Neuhaus, S.; Minor, D.; Singer, J.; Wachter, E.
	2012	Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the colorectal cancer family registry	Levine, A.; Win, A.; Buchanan, D.; Jenkins, M.; Baron, J.; Young, J.; Long, T.; Weisenberger, D.; Laird, P.; McCall, R.; Duggan, D.; Haile, R.
	2009	Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer	Smit, E.; Burgers, S.; Biesma, B.; Smit, H.; Eppinga, P.; Dingemans, A.; Joerger, M.; Schellens, J.; Vincent, A.; van Zandwijk, N.; Groen, H.
	2014	IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation	Smith, E.; Ruszkiewicz, A.; Jamieson, G.; Drew, P.